About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 42 record(s)
Req # CLC-A-2021-006
Obtain copies of all communications/correspondence/letters/emails, including attachments, between Canada Lands Company and the Ville de Montréal alluding or referring to the Silo No. 5 project since February 1, 2019, to the present day, December 8, 2021Organization: Canada Lands Company CLC Limited
311 page(s)
March 2022
March 2022
Req # CLC-A-2021-007
Obtain copies of all communications/correspondence/letters/emails, including attachments, between Canada Lands Company and Devimco alluding or referring to the Silo No. 5 project since February 1, 2019, to the present day, December 8, 2021Organization: Canada Lands Company CLC Limited
0 page(s)
March 2022
March 2022
Req # CLC-A-2021-008
Requesting winning submission proposals for French-to-English and English-to-French translation – RFP No. – CLC-COM105Organization: Canada Lands Company CLC Limited
26 page(s)
March 2022
March 2022
Req # A-2019-00003
•All records concerning or related to the federal government’s Directive on Automated Decision-Making that was prepared by or provided to the PMPRB. (January 1, 2019 to May 2, 2019). •A list of all pending access to information requests at the PMPRB (as of May 2, 2019). •All records relating to the impact of the pending amendments on national pharmacare or the impact of national pharmacare on the pending amendments (From May 2, 2019 to March 1, 2022). •The agenda and minutes for any meetings held by PMPRB executives between January 1, 2018 and May 1, 2019 that concerned the pending amendments. •All revisions or redrafts of the Regulatory Impact Analysis Statement (date of my first request to May 2, 2019). •All records relating to the new basket of countries under the pending amendments, including the inclusion or exclusion of particular countries (date of my first request down to May 2, 2019). •All records relating to the adoption of new pricing factors under the pending amendments (date of my first request down to May 2, 2019). •All records relating to changes in the reporting requirements for patentees under the pending amendments, especially the requirement to report confidential discounts or rebates (date of my first request down to May 2, 2019). •All records relating to a possible decision to distinguish between existing and new medicines in the application of the pending regulations (whether concerning pricing rules, reporting requirements, or any other legal obligation) (date of my first request down to May 2, 2019). •All studies, reports, or other documents prepared by or held by the PMPRB which deal with changes to the content of the pending regulations or the guidelines which are being developed (date of my first request down to May 2, 2019). •All communications regarding the proposed amendments between the PMPRB and one or more of the following organizations: Health Canada, ISED, or CIPO (date of my first request down to May 2, 2019). •All letters or other communications received between September 1, 2018 and May 1, 2019 that question or criticize the pending amendments (date of my first request down to May 2, 2019). •All records generated by the PMPRB or another federal government entity that comment on or analyze the report prepared by Mr. David Dodge (August 23, 2018 to May 2, 2019). •A copy of all training presentations concerning the pending amendments that were held or were supposed to be held between Setptember 1, 2019 and May 1, 2019.Organization: Patented Medicine Prices Review Board Canada
5557 page(s)
March 2022
March 2022
Req # A-2022-05127
Copies of all emails to/from Douglas Clark, Melanie Bourassa-Forcier, Tanya Potashnik and Health Canada officials from November 1, 2021 to January 31, 2022.Organization: Patented Medicine Prices Review Board Canada
20 page(s)
March 2022
March 2022
Req # CLC-A-2021-003
I wish to obtain a copy of all the documents related to the federal government transfer of the Federal Study Centre (1495 Heron Road, Ottawa, Ontario) to Canada Lands Company, including the final version of the Acquisition Business Plan prepared by Canada Lands Company for the redevelopment of the surplus federal property known as the Federal Study Centre, and including the description of CLC’s development concept and the description of CLC’s commitment to heritage preservation and/or commemoration. The Acquisition Business Plan was part of the documents annexed to the final Agreement of Purchase and Sale with the Government of Canada (Public Services and Procurement Canada) dated July 2020. Canada Lands Company is now the owner of the property located at 1495 Heron Road, Ottawa.Organization: Canada Lands Company CLC Limited
125 page(s)
August 2021
August 2021
Req # A-2021-10626
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and ASL Society of Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
0 page(s)
August 2021
August 2021
Req # A-2021-10632
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and the Arthritis Society over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
0 page(s)
August 2021
August 2021
Req # A-2021-10634
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Asthma Canada over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
0 page(s)
August 2021
August 2021
Req # A-2021-10636
Provide the preparation documents (excluding PowerPoint), meeting summaries and emails related to meetings and communications between PMPRB executives and Bayer Inc. over planned reforms to the PMPRB Guidelines from June 1, 2019 to June 7, 2021. Do not include emails related to Zoom, Microsoft Teams or other such mediums for the purposes of conducting the meeting, only the content of the meeting itself.Organization: Patented Medicine Prices Review Board Canada
0 page(s)
August 2021
August 2021